Stock Track | Avidity Biosciences (RNA) Soars 11.23% Pre-Market on HC Wainwright's Buy Rating Maintenance

Stock Track

2025/05/12

Shares of Avidity Biosciences, Inc. (RNA) are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its "Buy" rating on the company.

The maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have sparked renewed interest among investors, driving the stock's substantial pre-market gains.

While specific details of HC Wainwright's analysis were not immediately available, the maintained "Buy" rating suggests that the firm continues to see potential in Avidity Biosciences' business model and growth strategy. Investors are likely interpreting this as a positive sign for the company's future performance, leading to the notable increase in pre-market trading activity.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1103800728"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1103800728\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1103800728?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-12 20:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103800728","market":"nz","top_or_hot":-1,"title":"Stock Track | Avidity Biosciences (RNA) Soars 11.23% Pre-Market on HC Wainwright's Buy Rating Maintenance","media":"Stock Track","content":"<p>Shares of Avidity Biosciences, Inc. (RNA) are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its \"Buy\" rating on the company.</p>\n\n<p>The maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have sparked renewed interest among investors, driving the stock's substantial pre-market gains.</p>\n\n<p>While specific details of HC Wainwright's analysis were not immediately available, the maintained \"Buy\" rating suggests that the firm continues to see potential in Avidity Biosciences' business model and growth strategy. Investors are likely interpreting this as a positive sign for the company's future performance, leading to the notable increase in pre-market trading activity.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Avidity Biosciences (RNA) Soars 11.23% Pre-Market on HC Wainwright's Buy Rating Maintenance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Avidity Biosciences (RNA) Soars 11.23% Pre-Market on HC Wainwright's Buy Rating Maintenance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-12 20:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Avidity Biosciences, Inc. (RNA) are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its \"Buy\" rating on the company.</p>\n\n<p>The maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have sparked renewed interest among investors, driving the stock's substantial pre-market gains.</p>\n\n<p>While specific details of HC Wainwright's analysis were not immediately available, the maintained \"Buy\" rating suggests that the firm continues to see potential in Avidity Biosciences' business model and growth strategy. Investors are likely interpreting this as a positive sign for the company's future performance, leading to the notable increase in pre-market trading activity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RNA","symbol_name":"Avidity Biosciences, Inc.","start_time":0,"source_url":"","article_id":"1103800728","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103800728","pubTimestamp":1747051397,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Avidity Biosciences, Inc.  are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its \"Buy\" rating on the company.The maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have s","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RNA":"Avidity Biosciences, Inc."},"translate_title":"HC Wainwright维持买入评级，Avidity Biosciences(RNA)盘前飙升11.23%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RNA":1},"content_text":"Shares of Avidity Biosciences, Inc. (RNA) are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its \"Buy\" rating on the company.\nThe maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have sparked renewed interest among investors, driving the stock's substantial pre-market gains.\nWhile specific details of HC Wainwright's analysis were not immediately available, the maintained \"Buy\" rating suggests that the firm continues to see potential in Avidity Biosciences' business model and growth strategy. Investors are likely interpreting this as a positive sign for the company's future performance, leading to the notable increase in pre-market trading activity.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}